| Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome R Menendez, A Torres, R Zalacain, J Aspa, JJM Villasclaras, L Borderías, ... Thorax 59 (11), 960-965, 2004 | 451 | 2004 |
| Community-acquired pneumonia in the elderly: Spanish multicentre study R Zalacain, A Torres, R Celis, J Blanquer, J Aspa, L Esteban, ... European respiratory journal 21 (2), 294-302, 2003 | 257 | 2003 |
| Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome R Menéndez, A Torres, R Zalacaín, J Aspa, JJ Martín-Villasclaras, ... American journal of respiratory and critical care medicine 172 (6), 757-762, 2005 | 233 | 2005 |
| Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients R Menéndez, A Torres, F Rodríguez de Castro, R Zalacaín, J Aspa, ... Clinical Infectious Diseases 39 (12), 1783-1790, 2004 | 214 | 2004 |
| Prevalence and etiology of community-acquired pneumonia in immunocompromised patients MF Di Pasquale, G Sotgiu, A Gramegna, D Radovanovic, S Terraneo, ... Clinical Infectious Diseases 68 (9), 1482-1493, 2019 | 152 | 2019 |
| Effects of omalizumab in non-atopic asthma: results from a Spanish multicenter registry LP de Llano, MC Vennera, FJ Álvarez, JF Medina, L Borderías, C Pellicer, ... Journal of Asthma 50 (3), 296-301, 2013 | 147 | 2013 |
| 36th international symposium on intensive care and emergency medicine: Brussels, Belgium. 15-18 March 2016 RM Bateman, MD Sharpe, JE Jagger, CG Ellis, J Solé-Violán, ... Critical care 20, 13-182, 2016 | 146 | 2016 |
| Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study S Aliberti, LF Reyes, P Faverio, G Sotgiu, S Dore, AH Rodriguez, NJ Soni, ... The Lancet Infectious diseases 16 (12), 1364-1376, 2016 | 139 | 2016 |
| Tobacco smoking increases the risk for death from pneumococcal pneumonia S Bello, R Menéndez, T Antoni, S Reyes, R Zalacain, A Capelastegui, ... Chest 146 (4), 1029-1037, 2014 | 121 | 2014 |
| Initial management of pneumonia and sepsis: factors associated with improved outcome R Menéndez, A Torres, S Reyes, R Zalacain, A Capelastegui, J Aspa, ... European Respiratory Journal 39 (1), 156-162, 2012 | 121 | 2012 |
| Diferencias geográficas en la prevalencia de EPOC en España: relación con hábito tabáquico, tasas de mortalidad y otros determinantes JB Soriano, M Miravitlles, L Borderías, E Duran-Tauleria, FG Río, ... Archivos de Bronconeumología 46 (10), 522-530, 2010 | 120 | 2010 |
| Impact of initial antibiotic choice on mortality from pneumococcal pneumonia J Aspa, O Rajas, FR de Castro, MC Huertas, L Borderias, FJ Cabello, ... European Respiratory Journal 27 (5), 1010-1019, 2006 | 113 | 2006 |
| Etiology of bronchiectasis in a cohort of 2047 patients. An analysis of the Spanish historical bronchiectasis registry C Olveira, A Padilla, MÁ Martínez-García, D de la Rosa, RM Girón, ... Archivos de Bronconeumología (English Edition) 53 (7), 366-374, 2017 | 107 | 2017 |
| Predictors of severe sepsis among patients hospitalized for community-acquired pneumonia B Montull, R Menéndez, A Torres, S Reyes, R Méndez, R Zalacaín, ... PloS one 11 (1), e0145929, 2016 | 106 | 2016 |
| Guidelines for the diagnosis and treatment of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) SWG on Community-Acquired Archivos de Bronconeumología ((English Edition)) 41 (5), 272-289, 2005 | 85 | 2005 |
| Variants at the promoter of the interleukin-6 gene are associated with severity and outcome of pneumococcal community-acquired pneumonia I Martín-Loeches, J Solé-Violán, F Rodríguez de Castro, ... Intensive care medicine 38, 256-262, 2012 | 81 | 2012 |
| Genetic variability in the severity and outcome of community-acquired pneumonia J Solé-Violán, FR de Castro, MI García-Laorden, J Blanquer, J Aspa, ... Respiratory medicine 104 (3), 440-447, 2010 | 72 | 2010 |
| The Fcγ receptor IIA-H/H131 genotype is associated with bacteremia in pneumococcal community-acquired pneumonia J Solé-Violán, MI García-Laorden, JA Marcos-Ramos, FR de Castro, ... Critical care medicine 39 (6), 1388-1393, 2011 | 67 | 2011 |
| Effects of omalizumab in Aspergillus-associated airway disease LA Pérez-de-Llano, MC Vennera, A Parra, J Guallar, M Marin, O Asensio, ... Thorax 66 (6), 539-540, 2011 | 65 | 2011 |
| Sensitivity, specificity, and positivity predictors of the pneumococcal urinary antigen test in community-acquired pneumonia L Molinos, R Zalacain, R Menéndez, S Reyes, A Capelastegui, C Cillóniz, ... Annals of the American Thoracic Society 12 (10), 1482-1489, 2015 | 64 | 2015 |
